Skip to main content

BENEFICIOS DEL CONSUMO DE ACEITE DE OLIVA VIRGEN EXTRA, DURANTE EL EMBARAZO Y LA LACTANCIA, FRENTE A ENFERMEDADES METABOLICAS EN LA DESCENDENCIA

AGL2017-86927-R

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2017
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSIDAD PABLO DE OLAVIDE, DE SEVILLA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases

  • Gallego-Durán, Rocío
  • Montero-Vallejo, Rocío
  • Maya-Miles, Douglas
  • Lucena-Valera, Ana
  • Martín, Franz
  • Ampuero, Javier
  • Romero-Gómez, Manuel
Metabolic associated fatty liver disease (MAFLD) is the most prevalent form of liver disease worldwide, accounting for a high liver-related mortality and morbidity with extensive multi-organ involvement. This entity has displaced viral hepatitis as the main cause of severe forms of hepatic diseases, although the onset and transition of MAFLD stages still remains unclear. Nevertheless, innate and adaptive immune responses seem to play an essential role in the establishment and further progression of this disease. The immune system is responsible of safeguard and preserves organs and systems function, and might be altered under different stimuli. Thus, the liver suffers from metabolic and immune changes leading to different injuries and loss of function. It has been stablished that cell-cell crosstalk is a key process in the hepatic homeostasis maintenance. There is mounting evidence suggesting that MAFLD pathogenesis is determined by a complex interaction of environmental, genetic and host factors that leads to a full plethora of outcomes. Therefore, herein we will revisit and discuss the interplay between immune mechanisms and MAFLD, highlighting the potential role of immunological markers in an attempt to clarify its relationship., The research leading to these results has received funding from the Consejerı́a de Salud de la Junta de Andalucı́a under grant agreement PC-0148-2016-0148, the Ministerio de Economı́a y Competitividad under grant agreement AGL2017-86927-R, the Instituto de Salud Carlos III under grant agreements PI16/01842, PI19/01404, PI19/00589, IFI18/00041 and CD18/00126, and the Fondo Europeo de Desarrollo Regional (FEDER) in cooperation with the Consejerı́a de Salud de la Junta de Andalucı́a (PE-0451- 2018). RG-D has received the Andrew K Burroughs Fellowship from European Association for the Study of the Liver (EASL), the Aprendizaje de Nuevas Tecnologı́as fellowship from Asociación Española para el Estudio del Hı́gado (AEEH), and the CIBERehd Grant to support researcher’s mobility.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Contribution of Liver and Pancreatic Islet Crosstalk to β-Cell Function/Dysfunction in the Presence of Fatty Liver

  • López-Bermudo, Lucía
  • Luque-Sierra, Amparo
  • Maya-Miles, Douglas
  • Gallego-Durán, Rocío
  • Ampuero, Javier
  • Romero-Gómez, Manuel
  • Berná, Genoveva
  • Martín, Franz
Tissue-to-tissue crosstalk regulates organ function, according to growing data. This phenomenon is relevant for pancreatic β-cells and the liver, as both tissues are involved in glucose homeostasis and lipid metabolism. The ability to fine-tune regulation and adaptive responses is enabled through communication between pancreatic β-cells and the liver. However, the crosstalk between both tissues changes when metabolic dysregulation is present. Factors and cargo from extracellular vesicles (EVs) released by liver and pancreatic β-cells that reach the circulation form the words of this interaction. The molecules released by the liver are called hepatokines and are usually secreted in response to the metabolic state. When hepatokines reach the pancreatic islets several mechanisms are initiated for their protection or damage. In the case of the crosstalk between pancreatic β-cells and the liver, only one factor has been found to date. This protein, pancreatic derived factor (PANDER) has been proposed as a novel linker between insulin resistance (IR) and type 2 diabetes mellitus (T2D) and could be considered a biomarker for non-alcoholic fatty liver disease (NAFLD) and T2D. Furthermore, the cargo released by EVs, mainly miRNAs, plays a significant role in this crosstalk. A better knowledge of the crosstalk between liver and pancreatic β-cells is essential to understand both diseases and it could lead to better prevention and new therapeutic options., Funding from the following sources was used for this manuscript: AGL2017-86927-R and PID2020-116731RB-C21 from Ministerio de Ciencia e Innovación to FM and PC-0148- 2016-0148 from Junta de Andalucı́a to FM and RG-D.